- Posted
- Categories
-
- OpenPrescribing
OpenPrescribing Autumn 2024 Newsletter
This newsletter contains all the latest updates from OpenPrescribing.
Latest news and views from around the Bennett Institute
This newsletter contains all the latest updates from OpenPrescribing.
We’re starting a new project to prepare maternity data for use in OpenSAFELY, and we’re keen to find collaborators to work with.
How a team used OpenSAFELY to investigate how the COVID-19 pandemic impacted patterns of weight gain
Catch up with our OpenPrescribing webinars
Could you help us to improve the research that we are doing into COVID-19 vaccination?
We are hosting a webinar special in support of World Antimicrobial Resistance Awareness Week 2024
Thanks to George Davey Smith for his inspiring visit to the Bennett Institute.
We’ve analysed what we know about our OpenPrescribing user base. Here’s some information obout how many of you there are, what you all look at, and which organisations have signed up to our alerts.
We’ve launched a new project to understand who received which COVID-19 booster shots, and when, and the impacts of this on health outcomes.
It’s not too late to register for our 2nd Annual OpenSAFELY Symposium, which is happening in London on 25/26 November.
We’ve updated the DOAC measure following changes to the NHS England commissioning guidance.
We briefly summarise all the recent big and exciting developments in hospital medicines data.
Someone on the radio was musing about using retail data for health - we have some thoughts on that.
George is visiting the Bennett Institute on 30 September, to give two guest lectures
In the past 6 months we’ve been very productive at OpenSAFELY publishing 21 peer-reviewed papers on a variety of topics.
In this guest blog, Katie Bechman describes the proof-of-principle pharmacovigilance study she conducted with the help of her team from King’s College London, which used OpenSAFELY to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19.
This newsletter contains all the latest updates from OpenPrescribing
We’ve been producing estimates on the impact of Price Concessions since 2017. In this blog we describe the changes we’re making in how we estimate the costs.